Vanishing pachy-choroid in pachychoroid neovasculopathy under long-term anti-vascular endothelial growth factor therapy [PDF]
Background To investigate the diagnostic value of choroidal thickness in the definition of pachychoroid neovasculopathy (PNV), especially in eyes treated with anti-vascular endothelial growth factor (VEGF) therapy.
Benedikt Schworm +6 more
doaj +3 more sources
Choroidal caverns in pachychoroid neovasculopathy [PDF]
Apoorva Ayachit +3 more
doaj +4 more sources
Chronic choriocapillaris ischemia in dilated vortex vein region in pachychoroid neovasculopathy [PDF]
We evaluated choroidal congestion using multimodal imaging in pachychoroid neovasculopathy (PNV). In a retrospective case series of 100 eyes of 99 treatment-naïve PNV patients, their clinical records were reviewed and the corresponding multimodal imaging
Hidetaka Matsumoto +5 more
doaj +4 more sources
Ranibizumab non-response in pachychoroid neovasculopathy: Effects of switching to aflibercept [PDF]
AbstractNon-response to intravitreal ranibizumab represents a frequent problem in pachychoroid neovasculopathy (PNV). To investigate the effectivity of switching to aflibercept, the database of the Ludwig Maximilians University, Munich, was screened for patients fulfilling the following inclusion criteria: (i) diagnosis of PNV; (ii) inadequate response
Schworm, Benedikt +6 more
europepmc +6 more sources
Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy. [PDF]
This multicenter retrospective study was conducted to evaluate the 1-year treatment outcome of photodynamic therapy (PDT) combined with anti-vascular endothelial growth factor (VEGF) therapy for pachychoroid neovasculopathy (PNV).
Akiko Miki +7 more
doaj +4 more sources
Efficacy of aflibercept combined with 80% dose photodynamic therapy for pachychoroid neovasculopathy [PDF]
To evaluate the short-term treatment outcomes of 80% dose photodynamic therapy (PDT) combined with intravitreal aflibercept injection (IVA) for symptomatic pachychoroid neovasculopathy (PNV) in a working-age population.
Norihiko Nakagawa +3 more
doaj +4 more sources
Characteristics of pachychoroid neovasculopathy [PDF]
AbstractRecently, several research groups have reported a newly recognized clinical entity of choroidal neovascularization, termed pachychoroid neovasculopathy. However, its characteristics have yet to be well described. The purpose of this study was to investigate the clinical and genetic characteristics of pachychoroid neovasculopathy regardless of ...
Miho Tagawa +9 more
openaire +3 more sources
Pachychoroid neovasculopathy in a male patient: a case report [PDF]
Pachychoroid neovasculopathy is a form of type 1 (subretinal pigment epithelium) neovascularization characterized by the involvement of dilated choroidal vessels in areas of increased choroidal thickness. This disease was originally described in three white female patients.
Miguel Hage, Amaro +1 more
core +7 more sources
Progression of Subclinical Pachychoroid Neovasculopathy to an Active Neovascularization in the Presence of Acquired Vitelliform Lesions [PDF]
We describe a unique case of bilateral acquired vitelliform lesions in a 67‐year‐old‐female with pachychoroid associated with subretinal fluid in the right eye (OD) and a nonexudative choroidal neovascular membrane (CNVM) in the left eye (OS). Multimodal imaging performed at baseline and over the ensuing two years showed an increase in the OS ...
Manoj Soman +5 more
wiley +2 more sources
To report 3 cases of pachychoroid neovasculopathy, a form of Type 1 (sub-retinal pigment epithelium) neovascularization, occurring over areas of increased choroidal thickness and dilated choroidal vessels.A retrospective observational case series of three patients who underwent comprehensive ophthalmic examination and multimodal imaging with fundus ...
Claudine E, Pang, K Bailey, Freund
openaire +3 more sources

